Atreca Announces Appointment of Kristine M. Ball to its Board of Directors

NEXT STORY
Europe, the Biodefense Market, is anticipated to reach US$ 2,516.91 Mn in 2027 from US$ 1,286.58 Mn in 2019
PREV STORY
Inovalon Launches Cloud-Based Consumer Health Gateway Module Empowering Accelerated Patient Data Access and Healthcare Organization Compliance With The Interoperability Rule
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Atreca Announces Appointment of Kristine M. Ball to its Board of Directors

NEXT STORY
Europe, the Biodefense Market, is anticipated to reach US$ 2,516.91 Mn in 2027 from US$ 1,286.58 Mn in 2019
PREV STORY
Inovalon Launches Cloud-Based Consumer Health Gateway Module Empowering Accelerated Patient Data Access and Healthcare Organization Compliance With The Interoperability Rule
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Provides Pre-Clinical and Business Update

author_avatar
NASDAQ Market News

The dilutions segment held the largest share of the market in 2020, whereas the ointments segment is anticipated to register the highest CAGR during 2021–2028

author_avatar
NASDAQ Market News

Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

author_avatar
NASDAQ Market News